Found 5 matching trials
WT1 Peptid Vaccination in Carcinomas
PHASE2In this trial HLA-A2+ patients with WT1 expressing carcinomas are vaccinate...
Location
Hem&Onc Charité CBF
Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission
PHASE1This randomized phase I trial studies the side effects and best way to give...
Location
University of Chicago
Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers
PHASE2This study will test the safety and effectiveness of two vaccines on slowin...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy
PHASE2This study will determine the safety and effectiveness of an experimental v...
Location
National Cancer Institute (NCI), 9000 Rockville Pike
WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)
PHASE2In this trial, HLA-A2+ patients with active AML are vaccinated with a pepti...
Location
Hematology&Oncology Charité CBF